Ranked #3,359 of 8,699 institutional investors
Defilade Capital Management, L.P.
Emeryville, CA
$566M
US stock portfolio at live prices · today −$4.1M (−0.71%)
Live prices, last trade 11:46 AM ET
- Value at quarter end (Q3 2026)
- $599M
- Change from Q2 2026
- −$148.1M (−19.83%)
- Positions
- 28 · 7 new, 14 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$48.7M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesLLY 8.32%PFE 7.44%GILD 6.75%BMRN 6.48%AMGN 5.76%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| LLY Eli Lilly and Company | 34,774 | $47.1M | 8.32% | Reduced −11% |
| PFE Pfizer Inc. | 1,524,999 | $42.1M | 7.44% | Reduced −14% |
| GILD Gilead Sciences, Inc. | 226,572 | $38.2M | 6.75% | New |
| BMRN BioMarin Pharmaceutical Inc. | 601,922 | $36.7M | 6.48% | Reduced −12% |
| AMGN Amgen Inc. | 74,079 | $32.6M | 5.76% | New |
| ISRG Intuitive Surgical, Inc. | 71,860 | $29.2M | 5.16% | New |
| SYK Stryker Corporation | 81,524 | $25.7M | 4.54% | New |
| AXSM Axsome Therapeutics, Inc. | 175,371 | $22.9M | 4.05% | New |
| VEEV Veeva Systems Inc. | 69,141 | $18.5M | 3.26% | Reduced −71% |
| TMO Thermo Fisher Scientific Inc. | 26,469 | $18.0M | 3.17% | Reduced −49% |
| COGT Cogent Biosciences, Inc. | 631,645 | $17.2M | 3.04% | Added +61% |
| ORIC ORIC Pharmaceuticals, Inc. | 2,272,497 | $17.0M | 3.01% | Added +117% |
| VERA Vera Therapeutics, Inc. | 652,377 | $16.8M | 2.96% | New |
| AGIO Agios Pharmaceuticals, Inc. | 570,318 | $16.2M | 2.86% | Added +4% |
| BSX Boston Scientific Corporation | 350,778 | $14.9M | 2.64% | New |
| LRMR Larimar Therapeutics, Inc. | 4,934,439 | $14.8M | 2.62% | Added +34% |
| SOLV Solventum Corporation | 165,673 | $14.2M | 2.51% | Reduced −48% |
| OCUL Ocular Therapeutix, Inc. | 2,275,512 | $13.0M | 2.29% | Added +53% |
| NVST Envista Holdings Corporation | 534,430 | $12.4M | 2.19% | Reduced −26% |
| RVMD Revolution Medicines, Inc. | 71,186 | $11.6M | 2.04% | Reduced −14% |
| ENOV Enovis Corporation | 399,651 | $10.3M | 1.82% | Reduced −25% |
| OLMA Olema Oncology, Inc. | 1,440,157 | $10.3M | 1.81% | Added +56% |
| EVMN Evommune Inc | 1,430,573 | $10.1M | 1.79% | Added +80% |
| ICUI ICU Medical, Inc. | 54,435 | $9.5M | 1.67% | Reduced −49% |
| PACS PACS Group, Inc. | 164,984 | $7.3M | 1.29% | Reduced −24% |
| ELDN Eledon Pharmaceuticals, Inc. | 3,525,338 | $6.3M | 1.11% | Unchanged |
| BDTX Black Diamond Therapeutics, Inc. | 1,770,948 | $2.4M | 0.43% | Added +6% |
| MREO Mereo BioPharma Group plc | 7,558,756 | $2.0M | 0.36% | Unchanged |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| INSM Insmed Incorporated | 281,838 | $41.1M |
| BAX Baxter International Inc. | 1,459,380 | $37.2M |
| ZBH Zimmer Biomet Holdings, Inc. | 317,426 | $32.3M |
| ABT Abbott Laboratories | 285,778 | $29.7M |
| PTCT PTC Therapeutics, Inc. | 433,699 | $25.1M |
| PODD Insulet Corporation | 176,932 | $24.4M |
| ELAN Elanco Animal Health Incorporated | 864,080 | $22.4M |
| GKOS Glaukos Corporation | 66,519 | $15.8M |
| LNTH Lantheus Holdings, Inc. | 132,662 | $13.6M |
| TFX Teleflex Incorporated | 80,118 | $13.2M |
| GMED Globus Medical, Inc. | 139,637 | $9.4M |
| STAA STAAR Surgical Company | 322,126 | $7.9M |
| TYRA Tyra Biosciences, Inc. | 376,870 | $7.6M |
| DNLI Denali Therapeutics Inc. | 391,866 | $7.3M |